Metatropic dysplasia is a rare genetic disorder characterized by skeletal abnormalities that affect bone growth and development. It is estimated that the prevalence of metatropic dysplasia is approximately 1 in 1,000,000 individuals worldwide. This condition is inherited in an autosomal dominant manner, meaning that a person only needs to inherit one copy of the mutated gene from either parent to develop the disorder.
Metatropic dysplasia is typically diagnosed in infancy or early childhood and is characterized by short stature, a long and narrow chest, abnormal curvature of the spine (scoliosis), and joint abnormalities. Individuals with this condition may also experience respiratory difficulties due to the chest abnormalities.
Due to its rarity, there is limited information available regarding the prevalence of metatropic dysplasia in specific populations. However, it is important to note that the prevalence may vary among different ethnic groups and geographic regions. Genetic counseling and early intervention are crucial for individuals with metatropic dysplasia to manage symptoms and improve quality of life.